NCT07476560

Brief Summary

The goal of this clinical trial is to investigate whether mesh-suture affects wound complication rates, patient-reported quality of life, and operation time in adult patients undergoing surgery for small ventral hernias. The main questions it aims to answer are: Does mesh-suture reduce wound complication rates compared to planar mesh? Does mesh-suture improve patient-reported quality of life(QoL) and affect operation time compared to planar mesh? Comparison group: Researchers will compare standard treatment with planar mesh to the interventional treatment with mesh-suture to see whether mesh-suture leads to fewer complications, better quality of life, and shorter operation time. Participants will: Be randomized to receive either planar mesh or mesh-suture during hernia repair surgery. Undergo standardized preoperative assessment, including baseline data and QoL scoring. Attend a postoperative visit on day 7-13 for wound inspection and ultrasound. Complete QoL assessments at 90 days (telephone follow-up). Have operation time recorded and medical records reviewed for readmissions within 90 days.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
280

participants targeted

Target at P75+ for not_applicable

Timeline
80mo left

Started Jan 2026

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress6%
Jan 2026Dec 2032

Study Start

First participant enrolled

January 5, 2026

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

February 18, 2026

Completed
27 days until next milestone

First Posted

Study publicly available on registry

March 17, 2026

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2027

Expected
5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2032

Last Updated

March 17, 2026

Status Verified

March 1, 2026

Enrollment Period

2 years

First QC Date

February 18, 2026

Last Update Submit

March 12, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Surgical Site Occurrences (SSO) Assessed by Clinical Examination and Ultrasound

    Definition: We will apply the standardized CDC (Centers for Disease Control and Prevention ) and VHWG (Ventral Hernia Working Group) definitions for SSO. Evaluation: Clinical examination. Additionally, an ultrasound examination will be performed.

    7-13 days after operation

Secondary Outcomes (4)

  • Abdominal Hernia-Q Questionnaire

    preoperative, postoperative day 10, day 90

  • EQ-5D-5L Index Score

    preoperative, postoperative day 10, day 90

  • EQ-VAS (Visual Analogue Scale)

    preoperative, postoperative day 10, day 90

  • DURATION OF SURGERY

    The time interval from the first incision to the last stitch is set

Study Arms (2)

mesh suture

EXPERIMENTAL
Device: mesh suture

planar mesh

ACTIVE COMPARATOR
Device: planar mesh

Interventions

mesh suture

mesh suture

planar mesh

planar mesh

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Ventral hernia (maximum size 3 × 3 cm) measured with Ultrasound or CT.
  • Participants must be eligible for surgical repair using either mesh-suture or planar mesh

You may not qualify if:

  • Age \< 18 years.
  • Acute (emergent) operation.
  • Pregnancy.
  • Women with plans for future pregnancies.
  • Withdrawal of informed consent during admission.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Regionshospital Nordjylland

Hjørring, Denmark

RECRUITING

MeSH Terms

Conditions

Hernia, Abdominal

Condition Hierarchy (Ancestors)

HerniaPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • Nils Brandenburger

    Regionhospital Nordjylland

    STUDY CHAIR

Central Study Contacts

Vitaly A Gameza

CONTACT

Katrine Holte

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 18, 2026

First Posted

March 17, 2026

Study Start

January 5, 2026

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

December 31, 2032

Last Updated

March 17, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Ethics commettee requirements

Locations